Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of midazolam, fentanyl, and their combination on self-extubation frequency
IRCT201611159475N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in None comparing Midazolam monotherapy, Fentanyl monotherapy and Midazolam + fentanyl combination (3 arms). Primary endpoint: Frequency of self-extubation. Started Oct 2015; status: completed.
02
Drugs
midazolamfentanyl
Beyond the preview
Go deeper on IRCT201611159475N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201611159475N2.